James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

6 More Pharma Companies Selling Overpriced Drugs

Overpriced drugs are more common with the pharma industry than most realize, and these names are the worst offenders.

Why Dollar General Corp. (DG), St. Jude Medical, Inc. (STJ) and Express Scripts Holding Company (ESRX) Are 3 of Today’s Worst Stocks

Dollar General (DG), Express Scripts (ESRX) and St. Jude Medical (STJ) lead Thursday's bearish parade ... for understandable reasons.

Fitbit Inc (FIT) Could Be Saved by This Product

Fitbit stock hasn't been easy to own, but there's one crazy idea that could rekindle the FIT chart ... in time.

Sears Holdings Corp (SHLD) Can’t Stop Wetting the Bed

Sears Holdings (SHLD) posted a well-crafted second-quarter earnings press release, but Sears stock holders weren't bedazzled. They know Sears is in trouble.

Why Barrick Gold Corporation (USA) (ABX), Express, Inc. (EXPR) and Garmin Ltd. (GRMN) Are 3 of Today’s Worst Stocks

Barrick Gold (ABX), Express (EXPR) and Garmin (GRMN) shareholders couldn't wait for Wednesday's session to end.